Analyst
Evercore
Equibles does not estimate personal net worth.
Umur Rafat is recorded as Analyst at Evercore. Umur Rafat has spoken on 2 earnings calls across 2 companies, most recently for Elanco Animal Health Inc on May 6, 2026. Those appearances were for Elanco Animal Health Inc (ELAN) and Arcus Biosciences, Inc. (RCUS). The companies whose calls Umur Rafat spoke on are classified in the Healthcare sector.
“I thought I would focus a bit today on the non-innovation side for a second. And specifically, what I'm seeing is while there's all this focus on some of the new launches, your cattle business might have hit an all-time high, if I'm not mistaken.”
“Perhaps, first, the choice of dose being 100 milligrams for your first phase three, which admittedly is a Cabo combo. Is there anything to read into the choice of that 100 milligram dose relative to any early data you're seeing on the 150 and 200 milligrams?”
Evercore
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
